S. Schaaf

New and Repurposed Drugs for Pediatric Multidrug‐Resistant Tuberculosis. Practice‐based Recommendations

A. Cruz, A. Skrahina, G. Migliori, 2017, American journal of respiratory and critical care medicine.

Survival of children in Cape Town known to be vertically infected with HIV-1.

G. Hussey, S. Potgieter, R. Reijnhart, 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study

A. Mandalakas, A. Hesseling, K. Snow, 2017, BMC Infectious Diseases.

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.

G. Maartens, E. Variava, G. Meintjes, 2021, The Lancet. Infectious diseases.

Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis

A. Benedetti, D. Menzies, R. Platt, 2021, BMC Medical Research Methodology.

Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis

M. Cotton, H. Rabie, A. Hesseling, 2017, Expert opinion on pharmacotherapy.

Managing multidrug-resistant tuberculosis in children: review of recent developments

H. S. Schaaf, A. Hesseling, A. Garcia-Prats, 2014, Current opinion in infectious diseases.

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study

G. Maartens, J. Campbell, D. Menzies, 2022, The Lancet. Infectious diseases.

Unsuspected fatal drug-resistant TB in a child.

M. Cotton, H. Rabie, K. Hoek, 2010 .